The independent platform for news, articles and advice for professionals in laboratory medicine

Possible reasons for successful cross-species viral spread

Infectious disease emergence is often the result of a pathogen entering a new host species, as highlighted by the current SARS-CoV-2 pandemic. However, most cross-species transmissions fail to establish in the newly-infected species.

In a new study entitled ‘Virulence mismatches in index hosts shape the outcomes of cross-species transmission’ (Proc Natl Acad Sci U S A 2020 Oct 29; 202006778. doi: 10.1073/pnas.2006778117. Online ahead of print), led by a team of researchers at the University of Glasgow, scientists found disease progression was accelerated, which reduced the chances of onward transmission, when the original host and the new host were physiologically or genetically more dissimilar.

For diseases to emerge, pathogens not only need to infect a novel host, but also be subsequently transmitted from one individual to another – a critical step. Why some pathogens succeed at this point while others fail is not well understood.

In this study, the researchers analysed hundreds of published infection experiments involving the transfer of rabies virus – a dangerous pathogen able to infect and cause death in all mammals – from one host species to another.

The study found that rabies virus strains originating in bats – and those transferred from species with warmer body temperatures to those with a cooler body temperature – tended to kill the first infected host too fast for successful onward transmission. The same was true as the genetic distance between the original and infected host species increased.

Dr Roman Biek (Reader at the University of Glasgow’s Institute of Biodiversity, Animal Health and Comparative Medicine) said: “Our work shows how careful analysis of previous infection experiments can pinpoint small changes in the interaction between pathogen and host that may either help or hinder disease emergence, including emergence of new human infectious diseases. This is why investigating the factors which affect the clinical outcomes of cross-species transmission in the first novel host individual infected, the index host, is important, as these outcomes can alter the likelihood of the pathogen spreading further.“

www.glasgow.ac.uk

Upcoming Events

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
16 May, 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24 May, 2024

Med-Tech Innovation Expo

NEC, Birmingham
5-6 June, 2024

UK NEQAS Blood Coagulation: Clinical and Laboratory Haemostasis 2024

Sheffield Hallam University
5-6 June, 2024

LabMedUK24

DoubleTree by Hilton Brighton Metropole
10-12 June, 2024

Infection Diagnostics Symposium 2024

IET Austin Court, Birmingham
26-27 June, 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
16 May, 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24 May, 2024

Med-Tech Innovation Expo

NEC, Birmingham
5-6 June, 2024

UK NEQAS Blood Coagulation: Clinical and Laboratory Haemostasis 2024

Sheffield Hallam University
5-6 June, 2024

LabMedUK24

DoubleTree by Hilton Brighton Metropole
10-12 June, 2024

Infection Diagnostics Symposium 2024

IET Austin Court, Birmingham
26-27 June, 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025